Erratum: Chemokine-Containing Exosomes Are Released From Heat-Stressed Tumor Cells via Lipid Raft-Dependent Pathway and Act as Efficient Tumor Vaccine (J. Immunol. (2011) 186: 2219-2228) DOI: 10.4049/jimmunol.1002991);Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2219-2228

  Chen, Taoyong ^a   Guo, Jun ^a,c   Yang, Mingjin ^a,b   Zhu, Xuhui ^a   Cao, Xuetao ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; GLYCOPROTEIN P 15095; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EXOCYTOSIS; EXOSOME; HEAT STRESS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LIPID RAFT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY;

EID: 79951838013     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.2300469     Document Type: Erratum

References (50)

1. Stoorvogel, W., M. J. Kleijmeer, H. J. Geuze, and G. Raposo. 2002. The biogenesis and functions of exosomes. Traffic 3: 321-330. (Pubitemid 34461042)
2. Théry, C., M. Ostrowski, and E. Segura. 2009. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9: 581-593.
3. Viaud, S., C. Théry, S. Ploix, T. Tursz, V. Lapierre, O. Lantz, L. Zitvogel, and N. Chaput. 2010. Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res. 70: 1281-1285.
4. Iero, M., R. Valenti, V. Huber, P. Filipazzi, G. Parmiani, S. Fais, and L. Rivoltini. 2008. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 15: 80-88. (Pubitemid 350286175)
5. Zitvogel, L., A. Regnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4: 594-600.
6. Wolfers, J., A. Lozier, G. Raposo, A. Regnault, C. Théry, C.Masurier, C. Flament, S. Pouzieux, F. Faure, T. Tursz, et al. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7: 297-303.
7. Théry, C., L. Duban, E. Segura, P. Véron, O. Lantz, and S. Amigorena. 2002. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 3: 1156-1162.
8. André, F., N. Chaput, N. E. Schartz, C. Flament, N. Aubert, J. Bernard, F. Lemonnier, G. Raposo, B. Escudier, D. H. Hsu, et al. 2004. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172: 2126-2136.
9. Chaput, N., N. E. Schartz, F. André, J. Taïeb, S. Novault, P. Bonnaventure, N. Aubert, J. Bernard, F. Lemonnier, M. Merad, et al. 2004. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol. 172: 2137-2146.
10. Viaud, S., M. Terme, C. Flament, J. Taieb, F. André, S. Novault, B. Escudier, C. Robert, S. Caillat-Zucman, T. Tursz, et al. 2009. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS ONE 4: e4942.
11. Escudier, B., T. Dorval, N. Chaput, F. André, M. P. Caby, S. Novault, C. Flament, C. Leboulaire, C. Borg, S. Amigorena, et al. 2005. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J. Transl. Med. 3: 10.
12. Morse, M. A., J. Garst, T. Osada, S. Khan, A. Hobeika, T. M. Clay, N. Valente, R. Shreeniwas, M. A. Sutton, A. Delcayre, et al. 2005. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med. 3: 9.
13. Andreola, G., L. Rivoltini, C. Castelli, V. Huber, P. Perego, P. Deho, P. Squarcina, P. Accornero, F. Lozupone, L. Lugini, et al. 2002. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195: 1303-1316.
14. Alonso, R., M. C. Rodríguez, J. Pindado, E. Merino, I. Mérida, and M. Izquierdo. 2005. Diacylglycerol kinase alpha regulates the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes. J. Biol. Chem. 280: 28439-28450.
15. Abusamra, A. J., Z. Zhong, X. Zheng, M. Li, T. E. Ichim, J. L. Chin, and W. P. Min. 2005. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol. Dis. 35: 169-173.
16. Kim, J. W., E. Wieckowski, D. D. Taylor, T. E. Reichert, S. Watkins, and T. L. Whiteside. 2005. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin. Cancer Res. 11: 1010-1020.
17. Millimaggi, D., M. Mari, S. D'Ascenzo, E. Carosa, E. A. Jannini, S. Zucker, G. Carta, A. Pavan, and V. Dolo. 2007. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9: 349-357. (Pubitemid 46608302)
18. Clayton, A., J. P. Mitchell, J. Court, S. Linnane, M. D. Mason, and Z. Tabi. 2008. Human tumor-derived exosomes down-modulate NKG2D expression. J. Immunol. 180: 7249-7258.
19. Wieckowski, E. U., C. Visus, M. Szajnik, M. J. Szczepanski, W. J. Storkus, and T. L. Whiteside. 2009. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J. Immunol. 183: 3720-3730.
20. Xiang, X., A. Poliakov, C. Liu, Y. Liu, Z. B. Deng, J. Wang, Z. Cheng, S. V. Shah, G. J. Wang, L. Zhang, et al. 2009. Induction of myeloid-derived suppressor cells by tumor exosomes. Int. J. Cancer 124: 2621-2633.
21. Xie, Y., O. Bai, J. Yuan, R. Chibbar, K. Slattery, Y. Wei, Y. Deng, and J. Xiang. 2009. Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses. Cancer Res. 69: 7756-7766.
22. Castellana, D., F. Zobairi, M. C. Martinez, M. A. Panaro, V. Mitolo, J. M. Freyssinet, and C. Kunzelmann. 2009. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res. 69: 785-793.
23. Szajnik, M., M. Czystowska, M. J. Szczepanski, M. Mandapathil, and T. L. Whiteside. 2010. Tumor-derived microvesicles induce, expand and upregulate biological activities of human regulatory T cells (Treg). PLoS ONE 5: e11469.
24. Chalmin, F., S. Ladoire, G. Mignot, J. Vincent, M. Bruchard, J. P. Remy-Martin, W. Boireau, A. Rouleau, B. Simon, D. Lanneau, et al. 2010. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J. Clin. Invest. 120: 457-471.
25. Andre, F., N. E. Schartz, M. Movassagh, C. Flament, P. Pautier, P. Morice, C. Pomel, C. Lhomme, B. Escudier, T. Le Chevalier, et al. 2002. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360: 295-305. (Pubitemid 34874721)
26. Dai, S., D. Wei, Z. Wu, X. Zhou, X. Wei, H. Huang, and G. Li. 2008. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 16: 782-790.
27. Xiu, F., Z. Cai, Y. Yang, X. Wang, J.Wang, and X. Cao. 2007. Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes. J. Mol. Med. 85: 511-521.
28. Dai, S., X. Zhou, B. Wang, Q. Wang, Y. Fu, T. Chen, T. Wan, Y. Yu, and X. Cao. 2006. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells. J. Mol. Med. 84: 1067-1076.
29. Yang, Y., F. Xiu, Z. Cai, J. Wang, Q. Wang, Y. Fu, and X. Cao. 2007. Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells. J. Cancer Res. Clin. Oncol. 133: 389-399.
30. + CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J. Cell. Mol. Med. 14: 2655-2666.
31. Dai, S., T. Wan, B. Wang, X. Zhou, F. Xiu, T. Chen, Y. Wu, and X. Cao. 2005. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin. Cancer Res. 11: 7554-7563.
32. Chen, W., J. Wang, C. Shao, S. Liu, Y. Yu, Q. Wang, and X. Cao. 2006. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur. J. Immunol. 36: 1598-1607.
33. Chen, T., J. Guo, C. Han, M. Yang, and X. Cao. 2009. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J. Immunol. 182: 1449-1459.
34. Bianco, F., E. Pravettoni, A. Colombo, U. Schenk, T. Möller, M. Matteoli, and C. Verderio. 2005. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 174: 7268-7277. (Pubitemid 40705696)
35. Söderberg, A., A. M. Barral, M. Söderström, B. Sander, and A. Rosén. 2007. Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic. Biol. Med. 43: 90-99.
36. Chen, T., J. Guo, M. Yang, C. Han, M. Zhang, W. Chen, Q. Liu, J. Wang, and X. Cao. 2004. Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 103: 413-421. (Pubitemid 38145553)
37. Guo, J., M. Zhang, B. Wang, Z. Yuan, Z. Guo, T. Chen, Y. Yu, Z. Qin, and X. Cao. 2003. Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells. Int. J. Cancer 103: 212-220. (Pubitemid 35461513)
38. Liu, X., M. Yao, N. Li, C. Wang, Y. Zheng, and X. Cao. 2008. CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 112: 5961-4970.
39. Legler, D. F., O. Micheau, M. A. Doucey, J. Tschopp, and C. Bron. 2003. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18: 655-664. (Pubitemid 36588582)
40. Théry, C., M. Boussac, P. Véron, P. Ricciardi-Castagnoli, G. Raposo, J. Garin, and S. Amigorena. 2001. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 166: 7309-7318. (Pubitemid 32525606)
41. Lippincott-Schwartz, J., T. H. Roberts, and K. Hirschberg. 2000. Secretory protein trafficking and organelle dynamics in living cells. Annu. Rev. Cell Dev. Biol. 16: 557-589.
42. Mambula, S. S., and S. K. Calderwood. 2006. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J. Immunol. 177: 7849-7857.
43. Broquet, A. H., G. Thomas, J. Masliah, G. Trugnan, and M. Bachelet. 2003. Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J. Biol. Chem. 278: 21601-21606.
44. Lancaster, G. I., and M. A. Febbraio. 2005. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J. Biol. Chem. 280: 23349-23355.
45. Han, C., T. Chen, M. Yang, N. Li, H. Liu, and X. Cao. 2009. Human SCAMP5, a novel secretory carrier membrane protein, facilitates calcium-triggered cytokine secretion by interaction with SNARE machinery. J. Immunol. 182: 2986-2996.
46. Chamberlain, L. H., R. D. Burgoyne, and G. W. Gould. 2001. SNARE proteins are highly enriched in lipid rafts in PC12 cells: implications for the spatial control of exocytosis. Proc. Natl. Acad. Sci. USA 98: 5619-5624.
47. Lang, T., D. Bruns, D. Wenzel, D. Riedel, P. Holroyd, C. Thiele, and R. Jahn. 2001. SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J. 20: 2202-2213. (Pubitemid 32410590)
48. Salaün, C., G. W. Gould, and L. H. Chamberlain. 2005. Lipid raft association of SNARE proteins regulates exocytosis in PC12 cells. J. Biol. Chem. 280: 19449-19453.
49. Kay, J. G., R. Z. Murray, J. K. Pagan, and J. L. Stow. 2006. Cytokine secretion via cholesterol-rich lipid raft-associated SNAREs at the phagocytic cup. J. Biol. Chem. 281: 11949-11954.
50. Puri, N., and P. A. Roche. 2006. Ternary SNARE complexes are enriched in lipid rafts during mast cell exocytosis. Traffic 7: 1482-1494.